These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7095240)

  • 1. Facial and sublingual temperature changes following intravenous glucose injection in diabetics.
    Hillson RM; Hockaday TD
    Diabete Metab; 1982 Mar; 8(1):15-9. PubMed ID: 7095240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chlorpropamide alcohol flush test in diabetes mellitus: methods for objective evaluation.
    Jerntorp P
    Scand J Clin Lab Invest; 1983 May; 43(3):249-54. PubMed ID: 6622970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm.
    Panarotto D; Ardilouze JL; Tessier D; Maheux P
    Metabolism; 2000 Aug; 49(8):1055-62. PubMed ID: 10954026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study.
    Sicree RA; Zimmet PZ; Dunstan DW; Cameron AJ; Welborn TA; Shaw JE
    Diabet Med; 2008 Mar; 25(3):296-302. PubMed ID: 18307457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorpropamide-alcohol flushing and plasma chlorpropamide concentrations in diabetic patients on maintenance chlorpropamide therapy.
    Hillson RM; Smith RF; Dhar H; Moore RA; Hockaday TD
    Diabetologia; 1983 Mar; 24(3):210-2. PubMed ID: 6840427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On plasma chlorpropamide, body weight and sex difference in chlorpropamide alcohol flush (CPAF).
    Jerntorp P; Almér LO
    Diabetes Res; 1984 Nov; 1(4):223-6. PubMed ID: 6529894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
    Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
    Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in men.
    Almdal T; Scharling H; Jensen JS; Vestergaard H
    Eur J Intern Med; 2008 Jan; 19(1):40-5. PubMed ID: 18206600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial skin temperature and the chlorpropamide/alcohol flush in diabetics.
    Radder JK; Box MC; Lemkes HH
    Lancet; 1980 Nov; 2(8202):1037. PubMed ID: 6107672
    [No Abstract]   [Full Text] [Related]  

  • 13. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives.
    Lao B; Czyzyk A; Szutowski M; Szczepanik Z
    Arzneimittelforschung; 1994 Jun; 44(6):727-34. PubMed ID: 8053971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of a positive result in the chlorpropamide-alcohol flush test in type I and type II diabetes].
    Dempe A; Jordan A
    Z Gesamte Inn Med; 1986 Feb; 41(3):69-72. PubMed ID: 3962392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.
    Malone JK; Yang H; Woodworth JR; Huang J; Campaigne BN; Halle JP; Yale JF; Grossman LD
    Diabetes Metab; 2000 Dec; 26(6):481-7. PubMed ID: 11173719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe.
    Balkau B
    Diabetes Metab; 2000 Sep; 26(4):282-6. PubMed ID: 11011220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
    Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic characteristics of patients with apparently normal fasting plasma glucose.
    Braatvedt G; Gamble G; Kyle C
    N Z Med J; 2006 Aug; 119(1240):U2123. PubMed ID: 16924274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of isolated post-challenge hyperglycaemia in Jamaican adults.
    Boyne MS; Sargeant LA; Bennett FI; Cooper RS; Wilks RJ; Forrester TE
    West Indian Med J; 2004 Jan; 53(1):7-11. PubMed ID: 15114886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of sleep time with diabetes mellitus and impaired glucose tolerance.
    Gottlieb DJ; Punjabi NM; Newman AB; Resnick HE; Redline S; Baldwin CM; Nieto FJ
    Arch Intern Med; 2005 Apr; 165(8):863-7. PubMed ID: 15851636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.